stockrow
Friday 6 November 2026
Export CELC’s income statement to Excel — free account
Celcuity, Inc.
CELC Healthcare Biotechnology
- EPS
- −38.5%
- Free cash flow
- −53.3%
- Total debt
- +658.7%
Quarter to June 2026, against a year earlier
65.85
1.81
+2.83%
Follow CELC
Alert me
Celcuity, Inc. (CELC) Current ratio
Celcuity, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 8.9×, down 1.6× from fiscal 2025 (10.5×). Over the past ten years it has ranged from 7.7× (fiscal 2024) to 42.4× (fiscal 2017); the current reading is higher than 27% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 10.5× | 36.80% |
| FY2024 | 7.7× | (42.61%) |
| FY2023 | 13.4× | (47.24%) |
| FY2022 | 25.5× | (25.26%) |
| FY2021 | 34.1× | 231.84% |
| FY2020 | 10.3× | (51.41%) |
| FY2019 | 21.1× | (44.52%) |
| FY2018 | 38.1× | (10.10%) |
| FY2017 | 42.4× | 219.07% |
| FY2016 | 13.3× | (26.52%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 8.9× | (27.47%) |
| Mar 2026 | 12.3× | 16.75% |
| Dec 2025 | 10.5× | (13.96%) |
| Sep 2025 | 12.3× | 167.38% |
| 34 more quarters | Free account |
Against its own ten years
Low 7.7×
High 42.4×
Ten-year median
18.1×
Current reading's percentile
27
Current ratio against peers
| Company | Current ratio |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | 64.1× |
| VRDN Viridian Therapeutics, Inc. compare | 14.5× |
| DYN Dyne Therapeutics, Inc. compare | 12.0× |
| IDYA IDEAYA Biosciences, Inc. compare | 9.0× |
| CELC Celcuity, Inc. | 8.9× |
| VKTX Viking Therapeutics, Inc. compare | 7.3× |
| DNLI Denali Therapeutics Inc. compare | 6.2× |
| TLX Telix Pharmaceuticals Limited compare | 2.0× |
| TARS Tarsus Pharmaceuticals, Inc. compare | 2.0× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)